To prednisone or not to prednisone? Is that the question?

The past couple of years have seen a resurgence of academic (and clinical) interest in the value of the corticosteroid prednisone in combination with other drugs in the treatment of men with advanced forms of prostate cancer. … READ MORE …

Abiraterone acetate in chemotherapy-naive mCRPC: full data published

An article published this week in the New England Journal of Medicine gives the full results of the Phase III trial of abiraterone acetate + prednisone in men with chemotherapy-naive, metastatic, castration-resistant prostate cancer (mCRPC). These data were originally reported at the ASCO annual meeting in 2011. … READ MORE …